Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
1
14%
Ph early_phase_1
1
14%
Ph phase_1
1
14%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(2)
Other(4)

Detailed Status

unknown4
Completed2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 21 (20.0%)
N/A2 (40.0%)

Trials by Status

unknown457%
completed229%
active_not_recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
active_not_recruitingnot_applicable

PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

NCT04560725
unknownnot_applicable

[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

NCT04693169
unknownearly_phase_1

Characterizing LAM With 11C-Choline PET/CT

NCT05087134
completedphase_1

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

NCT02004418
unknown

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

NCT02531672
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04560725Not Applicable

PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

Active Not Recruiting
NCT04693169Not Applicable

[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients

Unknown
NCT05087134Early Phase 1

Characterizing LAM With 11C-Choline PET/CT

Unknown
NCT02004418Phase 1

A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

Completed
NCT02531672

Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography

Unknown
NCT02462447

Carbon-11 Labeled Sarcosine in Prostate Cancer

Completed
NCT01377220Phase 2

Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7